You may have seen headlines recently claiming peptides like MOTS C or BPC 157 are back let's talk about what this means. In 2023, the FDA placed 19 commonly used peptides into Category The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York 503A vs. 503B: A Quick Guide to Compounding Pharmacy Designations & Regulations Is BPC157 Legal? WADA, FDA Status, and What You Need to Know peptides #fda #longevity #glp1 #precisionmedicine #compounding Katherine Erickson